NCT01028222 - A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Melanoma

Interventions

DRUG

Nilotinib

Nilotinib was provided as 200 mg hard gelatin capsules for oral use.

DRUG

DTIC

DTIC was supplied locally as sterile powder for i.v. infusion.

Trial Locations (49)

1090

Novartis Investigative Site, Brussels

1200

Novartis Investigative Site, Brussels

2060

Novartis Investigative Site, North Sydney

3000

Novartis Investigative Site, Leuven

3002

Novartis Investigative Site, East Melbourne

3084

Novartis Investigative Site, Heidelberg

5000

Novartis Investigative Site, Adelaide

8091

Novartis Investigative Site, Zurich

10021

Memorial Sloan Kettering Cancer Center, New York

16132

Novartis Investigative Site, Genova

20133

Novartis Investigative Site, Milan

20141

Novartis Investigative Site, Milan

21231

Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. Medical Oncology, Baltimore

35100

Novartis Investigative Site, Padua

45147

Novartis Investigative Site, Essen

47014

Novartis Investigative Site, Meldola

50937

Novartis Investigative Site, Cologne

53100

Novartis Investigative Site, Siena

55905

Mayo Clinic - Rochester Mayo Clinic- Gonda, Rochester

60612

Rush University Medical Center SC, Chicago

63110

Washington University School of Medicine CAMN107B2301, St Louis

72076

Novartis Investigative Site, Tübingen

75246

Baylor Health Care System/Sammons Cancer Center Baylor 2, Dallas

80045

University of Colorado Univ Colorado 2, Aurora

80336

Novartis Investigative Site, München

90024

University of California at Los Angeles UCLA, Los Angeles

91054

Novartis Investigative Site, Erlangen

100036

Novartis Investigative Site, Beijing

169610

Novartis Investigative Site, Singapore

91010-3000

City of Hope National Medical Center City of Hope national Med Ctr, Duarte

92093-0658

University of California San Diego - Moores Cancer Center UCSD Moores Cancer Center, La Jolla

94120-7999

California Pacific Medical Center California Pacific Med, San Francisco

60068-0736

Oncology Specialists, SC Dept.of Oncology Specialists, Park Ridge

02215

Dana Farber Cancer Institute DFCI - Brookline, Boston

44106-5000

Case Western Reserve Case Western, Cleveland

C1125ABE

Novartis Investigative Site, Buenos Aires

30150-281

Novartis Investigative Site, Belo Horizonte

20230-130

Novartis Investigative Site, Rio de Janeiro

01246-000

Novartis Investigative Site, São Paulo

M4N 3M5

Novartis Investigative Site, Toronto

M5G 1Z5

Novartis Investigative Site, Toronto

1081 HV

Novartis Investigative Site, Amsterdam

6525 GA

Novartis Investigative Site, Nijmegen

08036

Novartis Investigative Site, Barcelona

08907

Novartis Investigative Site, L'Hospitalet de Llobregat

SE-413 45

Novartis Investigative Site, Gothenburg

SE-205 02

Novartis Investigative Site, Malmo

SE-171 76

Novartis Investigative Site, Stockholm

SE-751 85

Novartis Investigative Site, Uppsala